Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: jmac who wrote (8120)	7/18/1999 5:45:00 PM
From: J. P.	Read Replies (3) \| Respond to of 9523

I think Pfizer has repeatedly demonstrated their ham-handedness with regards to managing their stock price. They were the recipients of a fine runup, but it was only on the strength of Viagra hopes and hypes, and that runup quickly faded south. Doing a 3:1 split was also a meat head play, as they could have done consecutive year 2:1 splits if the runup was to be as good as expected. Now making the street wait is yet another blunder. Buyers of stock want the managements to be upfront and predictable (the ultimate model for this is Microsoft, where you can set your watch by the fact that they'll come in a couple of pennies over "first call estimates", and then will talk down next quarter estimates). I also own a call option position in Pfizer. But my position was predicated on managment announcing earnings in a timely fashion! I am not happy at this moment having speculative money tied up in Pfizer, as due to these management shenanigans it has become more a 'hope and pray' position, than a 'confidence' position. My experience with 'hope and pray' is not good.